The burgeoning popularity of tirzepatide , initially for metabolic conditions, is creating significant attention within the British Isles, prompting a notable shift in hormone trends. Obtaining these compounds remains a complex landscape, with NHS provision currently limited and private clinics offering prescriptions at a premium . Worries are bein